[Cite as http://purl.org/au-research/grants/nhmrc/1132519]
Prof Mark Smyth
Prof Scott Burrows
Prof Rajiv Khanna
Prof David Thomas
Brief description This Program team will discover new things about immunity to cancer and virus infection and translate the information into novel therapies in patients with blood or solid cancers. The approaches will include new cellular or antibody therapies, alone or in combination. We will determine new predictive biomarkers to better select patients for therapy. We will overcome treatment resistance, improve the safety of combination therapies, and determine their best scheduling and dosing.
Funding Amount $AUD 9,443,113.30
Funding Scheme Program Grants